Nissui Pharmaceutical to Bolster Development of Culture Media for Regenerative Medicine Jun. 15, 2018 Filed Under: Industry Tagged With: cell culture, Nissui Pharmaceutical, regenerative medicineNissui Pharmaceutical Co. Ltd. (TYO:4550), a subsidiary of Nippon Suisan Kaisha Ltd. (TYO:1332), is looking to strengthen its business for…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:Sekisui Chemical Moves Into Cell Culture SectorNissan Chemical Eyes Global Expansion of High-Performance,…Mitsubishi Chemical to Produce Regenerative Medicine…Fujifilm, JSR Stand out Among Major Chemical–Material…Raw Material Shortages Create Difficulties in Biopharma…Tosoh Enables Simple Removal of Regenerative Medicine Cells…